Antibody levels remain high nine months after SARS-CoV-2 infection, as evidenced by tests conducted across an Italian city, highlighting the durability of the immune response and informing vaccination strategies and public health measures.
March 2022
Almost all patients who lost their sense of smell due to COVID-19 regained olfactory function a year later, providing insights into the natural history of anosmia associated with SARS-CoV-2 infection and informing patient counseling and management strategies.
March 2022
Reports of neuro-psychiatric manifestations associated with COVID-19 continue to rise, underscoring the need for comprehensive neurological assessment, early intervention, and long-term follow-up care to address the diverse spectrum of neurological sequelae in affected individuals.
Februery 2022
Atherogenic dyslipidemia on admission is associated with poorer outcomes in people hospitalized for COVID-19, highlighting the importance of lipid management and cardiovascular risk assessment in COVID-19 patients to optimize clinical outcomes and reduce mortality rates.
Februery 2022
Role of inflammation and the immune system in the development of osteoarthritis is described, providing insights into disease pathogenesis and potential targets for therapeutic intervention to alleviate symptoms and slow disease progression.
Februery 2022
Significant reduction in household transmission of SARS-CoV-2 is observed with one dose of vaccines, underscoring the importance of vaccination in controlling community spread and supporting public health efforts to mitigate the COVID-19 pandemic.
Februery 2022
Less exposure to UVB light is associated with an increased risk of colorectal cancer, emphasizing the importance of sun protection measures and vitamin D supplementation to mitigate cancer risk in susceptible populations.
Februery 2022
Prescription medications for children declined by more than a quarter during the first eight months of the pandemic, prompting an exploration of the underlying factors and potential implications for pediatric healthcare delivery and patient outcomes.
Februery 2022
Vaccines, therapeutics, and diagnostics for SARS-CoV-2 should not be limited to the spike protein, as other viral components may also serve as viable targets for intervention, supporting a holistic approach to COVID-19 prevention and treatment strategies.
Februery 2022
Review provides insights into the epidemiology, clinical course, and viral load dynamics of SARS-CoV-2 infection in children and adolescents, informing pediatric healthcare practices and public health strategies for managing the COVID-19 pandemic.
Februery 2022